Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

Sophia G. Liva; Yu Chou Tseng; Anees M. Dauki; Michael G. Sovic; Trang Vu; Sally E. Henderson; Yi Chiu Kuo; Jason A. Benedict; Xiaoli Zhang; Bryan Remaily; Ching-Shih Chen; Christopher C. Coss

doi:https://doi.org/10.15252/emmm.201809910

doi.org/10.15252/emmm.201809910

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

,

,

..., Christopher C. Coss

18

EMBO Molecular Medicine11.10

Volume: 12, Issue: 2

Published: Jan 13, 2020

Abstract

Article13 January 2020Open Access Source DataTransparent process Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor Sophia G Liva Sophia G Liva Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA Search for more papers by this author Yu-Chou Tseng Yu-Chou Tseng Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The...

Paper Fields

Paper Details

Title

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

DOI

doi.org/10.15252/emmm.201809910

Published Date

Jan 13, 2020

Journal

EMBO Molecular Medicine

Volume

12

Issue

2

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History